A groundbreaking anticancer treatment technology that selectively targets cancer cell lysosomes and overcomes drug resistance has been developed by Professor Ja-Hyoung Ryu and his research team in the Department of Chemistry at UNIST.
Smith+Nephew and HOPCo Partner to Enhance Musculoskeletal Care
What You Should Know: – Smith+Nephew, a global leader in medical technology, has announced a strategic partnership with Healthcare Outcomes Performance Company (HOPCo), the world’s